Unknown

Dataset Information

0

Cyclipostins and cyclophostin analogs inhibit the antigen 85C from Mycobacterium tuberculosis both in vitro and in vivo.


ABSTRACT: An increasing prevalence of cases of drug-resistant tuberculosis requires the development of more efficacious chemotherapies. We previously reported the discovery of a new class of cyclipostins and cyclophostin (CyC) analogs exhibiting potent activity against Mycobacterium tuberculosis both in vitro and in infected macrophages. Competitive labeling/enrichment assays combined with MS have identified several serine or cysteine enzymes in lipid and cell wall metabolism as putative targets of these CyC compounds. These targets included members of the antigen 85 (Ag85) complex (i.e. Ag85A, Ag85B, and Ag85C), responsible for biosynthesis of trehalose dimycolate and mycolylation of arabinogalactan. Herein, we used biochemical and structural approaches to validate the Ag85 complex as a pharmacological target of the CyC analogs. We found that CyC7?, CyC8?, and CyC17 bind covalently to the catalytic Ser124 residue in Ag85C; inhibit mycolyltransferase activity (i.e. the transfer of a fatty acid molecule onto trehalose); and reduce triacylglycerol synthase activity, a property previously attributed to Ag85A. Supporting these results, an X-ray structure of Ag85C in complex with CyC8? disclosed that this inhibitor occupies Ag85C's substrate-binding pocket. Importantly, metabolic labeling of M. tuberculosis cultures revealed that the CyC compounds impair both trehalose dimycolate synthesis and mycolylation of arabinogalactan. Overall, our study provides compelling evidence that CyC analogs can inhibit the activity of the Ag85 complex in vitro and in mycobacteria, opening the door to a new strategy for inhibiting Ag85. The high-resolution crystal structure obtained will further guide the rational optimization of new CyC scaffolds with greater specificity and potency against M. tuberculosis.

SUBMITTER: Viljoen A 

PROVIDER: S-EPMC5827452 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cyclipostins and cyclophostin analogs inhibit the antigen 85C from <i>Mycobacterium tuberculosis</i> both <i>in vitro</i> and <i>in vivo</i>.

Viljoen Albertus A   Richard Matthias M   Nguyen Phuong Chi PC   Fourquet Patrick P   Camoin Luc L   Paudal Rishi R RR   Gnawali Giri R GR   Spilling Christopher D CD   Cavalier Jean-François JF   Canaan Stéphane S   Blaise Mickael M   Kremer Laurent L  

The Journal of biological chemistry 20180104 8


An increasing prevalence of cases of drug-resistant tuberculosis requires the development of more efficacious chemotherapies. We previously reported the discovery of a new class of cyclipostins and cyclophostin (CyC) analogs exhibiting potent activity against <i>Mycobacterium tuberculosis</i> both <i>in vitro</i> and in infected macrophages. Competitive labeling/enrichment assays combined with MS have identified several serine or cysteine enzymes in lipid and cell wall metabolism as putative tar  ...[more]

Similar Datasets

| S-EPMC6126352 | biostudies-literature
| S-EPMC3318338 | biostudies-literature
| S-EPMC3548330 | biostudies-literature
| S-EPMC5603573 | biostudies-literature
| S-EPMC3597060 | biostudies-literature
| S-EPMC4794995 | biostudies-literature
| S-EPMC4854729 | biostudies-literature
| S-EPMC2981290 | biostudies-literature
| S-EPMC5338015 | biostudies-literature
| S-EPMC3495175 | biostudies-literature